4.8 Article

Efficacy and tolerability of bevacizumab in patients with severe Covid-19

Related references

Note: Only part of the references are listed.
Review Critical Care Medicine

Severe flu management: a point of view

Antoni Torres et al.

INTENSIVE CARE MEDICINE (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Review Public, Environmental & Occupational Health

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Alfonso J. Rodriguez-Morales et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Letter Critical Care Medicine

COVID-19, ECMO, and lymphopenia: a word of caution

Brandon Michael Henry

LANCET RESPIRATORY MEDICINE (2020)

Article Public, Environmental & Occupational Health

An evidence-based framework for priority clinical research questions for COVID-19

Carlyn Harris et al.

JOURNAL OF GLOBAL HEALTH (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Covid-19 in Critically Ill Patients in the Seattle Region - Case Series

Pavan K. Bhatraju et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

B. Cao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, General & Internal

Clinical Characteristics of Covid-19 in New York City

Parag Goyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Compassionate Use of Remdesivir for Patients with Severe Covid-19

J. Grein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Genetic Delivery of Bevacizumab to Suppress Vascular Endothelial Growth Factor-Induced High-Permeability Pulmonary Edema

Masaki Watanabe et al.

HUMAN GENE THERAPY (2009)

Article Critical Care Medicine

Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome

DR Thickett et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

Article Biochemistry & Molecular Biology

Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema

RJ Kaner et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)